Micropos Medical
Enabling accuracy in prostate cancer care
Micropos Medical is a Swedish medical device company that develops, manufactures, and sells technology enabling enhanced radiotherapy cancer treatment. Its product Raypilot® System, generates high precision as well as high efficiency through real-time tumour tracking in radiation treatment of prostate cancer. Raypilot is marketed in Europe and the US.
The Micropos Medical share is traded under the stock ticker MPOS on the Spotlight Stock Market.
For more information about the share, please visit Spotlight
Interim Reports
annual reports
Financial calendar
| DATE | EVENTS |
|---|---|
| 21 May 2025 | Micropos Medical – Annual general meeting |
| 21 May 2025 | Interim report Q1 2025 |
| 31 July 2025 | Interim report Q2 2025 |
| 31 October 2025 | Interim report Q3 2025 |
| 30 January 2026 | Interim report Q4/Year-end Report 2025 |
For additional information, please contact:
Richard Forsberg, CEO, Micropos Medical AB (publ)
+46-31-760 80 05, info@micropos.se
-
news
Webinar Recap: Augmented SBRT for Prostate Cancer
Webinar Recap: Augmented SBRT for Prostate CancerDate: September 25, 2025 On September 25th, leading oncology experts gathered virtually to share the latest advancements in precision techniques for prostate cancer treatment. […]
COMPANY INFO
LEARN MORE ABOUT OUR TEAM, BOARD AND OUR PRODUCTS
NEWSLETTER
Follow us on LinkedIn
Let’s keep in touch